Add BrightSurf on Google Email

Candidate drug that boosts protective brain protein in mice has potential to treat Alzheimer’s Disease

Researchers at UCLA Health identified a candidate small molecule, DDL-357, that increases concentrations of secreted clusterin, reducing toxic protein phospho-tau and improving mitochondrial function. The drug also improved memory in treated mice in maze-based cognitive tests.

SourceUniversity of California - Los Angeles Health Sciences·Journalnpj Drug Discovery·TypeRandomized controlled/clinical trial·DateMay 20, 2025

A groundbreaking discovery of a common master switch to cure Alzheimer’s, Parkinson’s, and other brain-related diseases

Davis Joseph's groundbreaking discovery identifies a common master switch that can cure multiple brain-related diseases with a single method. The unified theory establishes that regulating axon-based 4E-BP2 protein deamidation can control disease progression.

SourceFLOGEN Star Outreach·JournalInternational Journal of Molecular Sciences·TypeSystematic review·DateMay 19, 2025

Mass General Brigham researchers pinpoint ‘sweet spot’ for focused ultrasound to provide essential tremor relief

Researchers at Mass General Brigham have pinpointed a 'sweet spot' for focused ultrasound treatment to provide significant relief from essential tremor. The study identified a specific subregion of the brain's thalamus that can result in optimal and long-lasting tremor improvements while reducing side effects. With this breakthrough, p...

SourceMass General Brigham·JournalScience Advances·TypeObservational study·DateMay 14, 2025

Poor heart health increases risk of dementia for Black Americans

A new University of Georgia study found that Black Americans with high blood pressure and diabetes in midlife had significantly higher levels of a dementia-related biomarker over an 11-year period. Early intervention for these chronic health conditions could protect brain health and reduce neurodegenerative diseases later in life.

SourceUniversity of Georgia·JournalJournal of Racial and Ethnic Health Disparities·DateMay 12, 2025

Dementia rates in China are rising disproportionately

Alzheimer's disease and other dementias are rising rapidly in China due to population growth and high-risk factors like high blood sugar, smoking, and obesity. The study projects continued rise unless effective interventions are implemented.

SourcePLOS·JournalPLOS One·TypeObservational study·DateMay 7, 2025

Editing Parkinson's Disease – KAIST makes world's first discovery of an inflammatory RNA editing enzyme​

Researchers at KAIST have identified a key mechanism behind neuroinflammatory responses in Parkinson's disease, which is regulated by an RNA editing enzyme called ADAR1. This discovery suggests that targeting this enzyme could serve as a novel therapeutic strategy for treating the disease.

SourceThe Korea Advanced Institute of Science and Technology (KAIST)·JournalScience Advances·TypeExperimental study·DateMay 2, 2025

Empathy might be retained in Alzheimer’s disease

A new study led by University College London researchers found that people with Alzheimer's disease scored slightly higher on a measure of empathy than peers with mild cognitive impairment. Despite this, emotional reactivity to negative emotions was heightened among those with Alzheimer's disease, contributing to difficulties regulatin...

SourceUniversity College London·JournalAlzheimer s & Dementia·TypeSystematic review·DateApr 23, 2025

Treatment for mitochondrial diseases within reach

Researchers at the University of Gothenburg have discovered a molecule that helps more mitochondria function properly, improving energy production in cells from patients with POLG mutations. This breakthrough paves the way for a new treatment strategy and may have broader therapeutic use for other mitochondrial diseases.

SourceUniversity of Gothenburg·JournalNature·TypeExperimental study·DateApr 9, 2025

Dartmouth-led research team receives $13 million PCORI funding award to test the impact of video on visit communication for people with ALS

A dual-principal investigator research group led by Dartmouth and the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital will test the effectiveness of video as a communication tool during patient visits for people living with Amyotrophic Lateral Sclerosis (ALS) and their caregivers.

Mass General Brigham researchers reveal 17 modifiable risk factors shared by stroke, dementia, and late-life depression

Mass General Brigham researchers have identified 17 modifiable risk factors shared by stroke, dementia, and late-life depression. Modifying any one of these risk factors can reduce the risk of all three conditions, providing an opportunity to simultaneously reduce the burden of age-related brain diseases.

SourceMass General Brigham·JournalJournal of Neurology Neurosurgery & Psychiatry·TypeLiterature review·DateApr 3, 2025

Duke-NUS and NUS Medicine join forces to launch Systems Metabolomics Center for precision medicine

The Systems Metabolomics Centre will focus on three key areas: profiling populations of healthy people and those living with specific illnesses, leveraging state-of-the-art metabolomic technologies to drive biomarker discovery and metabolism research. The centre aims to develop non-invasive tests, detect diseases earlier and guide doct...

New cannabis formula will help epilepsy, multiple sclerosis sufferers

Scientists at the University of South Australia have developed a phospholipid complex to improve cannabidiol's effectiveness in treating epilepsy, multiple sclerosis, and other neurodegenerative diseases. The new formula increases cannabidiol's solubility by up to six times and improves its absorption in the gastrointestinal tract.

SourceUniversity of South Australia·JournalInternational Journal of Molecular Sciences·TypeExperimental study·DateMar 19, 2025

Stowers scientists uncover principles underlying the toxicity of “selfish” genes

Researchers found that selfish genes use self-assembly properties to harm cells, with aggregate size and distribution being key factors in toxicity. The study also reveals an evolutionary arms race between sabotage and salvation, where rapid evolution of 'selfish' genes can lead to their own destruction.

SourceStowers Institute for Medical Research·JournalPLOS Genetics·TypeExperimental study·DateMar 18, 2025

The flicker reveals the mechanisms of vision. Groundbreaking f-ORG technique can advance the diagnosis of retinal diseases

A new diagnostic method called flicker optoretinography (f-ORG) analyzes the retina's reaction to light, helping to detect danger before symptoms appear. The technique detects even minor changes in photoreceptors, providing valuable insights into retinal health.

SourceInstitute of Physical Chemistry of the Polish Academy of Sciences·JournalProceedings of the National Academy of Sciences·DateMar 12, 2025

Aligning Science Across Parkinson’s (ASAP) launches a second funding opportunity to accelerate novel tool development to advance Parkinson's disease research

The Aligning Science Across Parkinson’s (ASAP) initiative offers funding of up to $6M for research community members to develop sustainable tools for Parkinson’s disease research. The funding supports the development of preclinical models, detection reagents, and modulation agents to accelerate therapeutic research.